ArticleLeukemia2016

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.

K Canté-Barrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.